基石药业-B(02616)：谢芳已获委任为独立非执行董事

Core Points - 基石药业-B (02616) announced the appointment of Xie Fang as an independent non-executive director, chairman of the audit committee, and member of the remuneration committee, nomination committee, and investment committee, effective from November 1, 2025 [1] - He Ye resigned from his position as an independent non-executive director, chairman of the audit committee, and member of the remuneration committee, nomination committee, strategic committee, and investment committee, effective at the end of business on October 31, 2025, to devote more time to personal matters [1]